Jackie Fielding joins Ossiform® Board of Directors
Ossiform Ltd. & Ossiform ApS
85 Great Portland Street, London, England, W1W 7LT
Oslogade 1, 5000 Odense,...
Posts by Ossiform
Ossiform® obtains ISO 13485 certification
(September 26, Odense): Ossiform® is pleased to announce that it has obtained the ISO 13485 certification thro...
Microstructural analysis of P3D Scaffolds
Investigating bioceramic scaffolds with micro-CT
In a recent study, microcomputed tomography (micro-CT) was u...
Bone regeneration is an advancing field of research
Unlike the structure and hierarchy of bone tissues, the process of bone regeneration remains an enigma and an ...
Democratizing 3D Bone Printing for Medical Innovations
The democratization of 3D bone printing
The democratization of advanced technology, particularly in 3D bone p...
Why 3D bone printing is a foundation for pioneering research
Transformative research is unpredictable, and the pioneers of such research may not always realize when they a...
CELLINK and Ossiform® Enter a Strategic Partnership to launch Ossi Ink, a printable bioink based on Ossiform®’s P3D Bone material
A printable bioink based on Ossiform®’s P3D Bone material
CELLINK and Ossiform® look to capitalize on synerg...
Ossiform® supports frontier research through the P3D Scaffolds Research Grant (2023)
Ossiform® has successfully provided researchers at the University of Oxford and the University of Southern Den...
Hydrogels versus Scaffolds: When to Choose What?
The 2D Culture Paradigm
Our collective understanding of various cell-based processes is primarily derived fr...
Human-derived osteoclasts cultured on a P3D Scaffold
CD14+ monocytes were isolated from blood of human donors and subsequently differentiated into mature osteoclas...